Patriot Financial Group Insurance Agency’s Supernus Pharmaceuticals SUPN Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-652	Closed	-$19K	–	1777
2022 Q2	$19K	Sell	652 -35	-5%	-$1K	﹤0.01%	1033
2022 Q1	$22K	Sell	687 -7	-1%	-$215	﹤0.01%	1058
2021 Q4	$20K	Hold	694	–	–	﹤0.01%	1230
2021 Q3	$19K	Buy	694 +35	+5%	+$939	﹤0.01%	1242
2021 Q2	$20K	Hold	659	–	–	﹤0.01%	1184
2021 Q1	$17K	Hold	659	–	–	﹤0.01%	1175
2020 Q4	$17K	Hold	659	–	–	﹤0.01%	1040
2020 Q3	$14K	Hold	659	–	–	﹤0.01%	930
2020 Q2	$16K	Buy	659 +13	+2%	+$287	0.01%	823
2020 Q1	$12K	Sell	646 -354	-35%	-$7.44K	0.01%	810
2019 Q4	$24K	Hold	1,000	–	–	0.01%	637
2019 Q3	$27K	Hold	1,000	–	–	0.01%	569
2019 Q2	$33K	Buy	+1,000	New	+$34.3K	0.01%	525

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Patriot Financial Group Insurance Agency's SUPN Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Supernus Pharmaceuticals (SUPN) in Q3 2022, closing a stake of 652 shares — an estimated $19K sold.

Patriot Financial Group Insurance Agency first reported a position in SUPN in Q2 2019 and held it in 13 quarters. The position peaked at $33K in Q2 2019. 244 funds tracked by Wall St. Rank hold SUPN as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining Supernus Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 652 Supernus Pharmaceuticals shares in Q3 2022, an estimated $19K.
Patriot Financial Group Insurance Agency first reported a position in Supernus Pharmaceuticals in Q2 2019 and held it in 13 quarters.
Patriot Financial Group Insurance Agency's Supernus Pharmaceuticals position peaked at $33K in Q2 2019.
244 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.